Friday - June 26, 2026

Category Archives: Science

Diffuse Large B-Cell Lymphoma Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insights 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical … Continue reading →

The Chronic Inflammatory Demyelinating Polyneuropathy Therapeutics Market Size in the 7MM is going to be ~USD 1,843 million in 2025, and expected to grow with a CAGR of 7.6% during the forecast perio

DelveInsight’s “Chronic Inflammatory Demyelinating Polyneuropathy Market Insights, Epidemiology, and Market Forecast – 2036” report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the Chronic Inflammatory Demyelinating Polyneuropathy market trends in the United States, EU4 (Germany, France, Italy, … Continue reading →

Hemophilia A Pipeline Gains Momentum: 40+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Hemophilia A Pipeline Insights 2026” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in the Hemophilia A pipeline landscape. It covers the Hemophilia A pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

The Diabetic Neuropathy Therapeutics Market Size (7MM) is projected to grow with a significant CAGR over the forecast period of 2026-2036

DelveInsight’s “Diabetic Neuropathy Market Insights, Epidemiology, and Market Forecast – 2036” report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the Diabetic Neuropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the … Continue reading →

Claudin 18.2 Directed Therapies Market is Projected to Reach USD 16 Billion by 2036, Driven by Expanding Precision Oncology Applications and Robust Pipeline Advancements | DelveInsight

The Claudin 18.2 Directed Therapies Market is poised for significant growth, driven by the increasing adoption of biomarker-driven oncology treatments, rising prevalence of gastric and pancreatic cancers, expanding use of companion diagnostics, and advancements in antibody-based therapeutics. The expected launch … Continue reading →

Aortic Aneurysm Stent Grafts Market to Grow at a CAGR of 5.71% Through 2030, Driven by Rising Aneurysm Prevalence and Advancements in Endovascular Repair Technologies

The Aortic Aneurysm Stent Grafts Market is witnessing significant growth owing to the increasing burden of vascular diseases, rising geriatric population, growing preference for minimally invasive aneurysm repair procedures, and continuous technological advancements in stent graft systems. Leading companies including … Continue reading →

Coronary Microvascular Dysfunction Market is Anticipated to Witness Significant Growth by 2034, Driven by Rising Disease Awareness, Advancements in Diagnostics, and Emerging Therapeutic Opportunities

The Coronary Microvascular Dysfunction Market is growing steadily due to rising awareness, improved diagnostics, and increasing recognition of CMD in ischemic heart disease. Advanced tools such as CMR, PET, invasive coronary assessment, and technologies like the CoroFlow Cardiovascular System are … Continue reading →

PROTAC Market is Expected to Reach USD 16 Billion by 2036, Driven by the Emergence of Targeted Protein Degradation Therapies and Expanding Oncology Applications | DelveInsight

The PROTAC Market is witnessing remarkable growth driven by advancements in targeted protein degradation technologies, increasing focus on previously undruggable targets, rising investments in oncology drug development, and growing adoption of precision medicine approaches. The anticipated launch of emerging therapies … Continue reading →